Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells
- 5 February 1994
- journal article
- research article
- Published by Wiley in Journal of Medical Primatology
- Vol. 23 (2-3) , 75-82
- https://doi.org/10.1111/j.1600-0684.1994.tb00105.x
Abstract
Homologous SIVsm stocks were generated by passage of a macaque isolate of SIVsm (SIVsm/E660) in human CEM x 174 cells or macaque peripheral blood mononuclear cells. Macaques were immunized with whole inactivated SIV vaccine consisting of virus generated by transfection of CEM x 174 cells with the SIVsmH4 clone and were challenged with either cell-free stock. Only vaccinees challenged with virus generated in human cells were protected from infection. This confirms the species-specificity of whole inactivated vaccine-mediated protection.Keywords
This publication has 14 references indexed in Scilit:
- Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virusAIDS, 1993
- Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency VirusAIDS Research and Human Retroviruses, 1993
- Specific and non-specific immunity and protection of macaques against SIV infectionVaccine, 1992
- Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and VaccinesScience, 1992
- AIDS vaccine developmentsNature, 1992
- AIDS vaccine developmentsNature, 1992
- AIDS vaccine developmentsNature, 1992
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- Anti-cell antibody in macaquesNature, 1991
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989